New genetic clues illuminate the biology of stuttering

A major leap forward comes from a study just published (20 August 2025) in Molecular Psychiatry, where researchers carried out exome sequencing in 85 parent–child trios—each with a child experiencing either transient or persistent stuttering—to uncover de novo (new in the child, absent from both parents) gene variants linked to stuttering.
 

Unveiling new genetic suspects

This investigation identified several compelling candidate genes:

• SPTBN1: A pathogenic variant detected in a child with persistent stuttering.
• Likely pathogenic variants found in PRPF8, TRIO, and ZBTB7A-genes previously tied to various neurodevelopmental disorders, some involving speech.
• Two additional genes - FLT3 and IREB2 - emerged as newly discovered genes of interest.

Together, these add up to six new genes potentially involved in stuttering, representing the first direct genetic link between stuttering and broader neurodevelopmental conditions

Unpacking the complexity

Importantly, further analyses of gene expression in developing and adult human brains, as well as data from genome-wide studies on structural brain connectivity, revealed no shared brain processes among the dozen genes now implicated in monogenic forms of stuttering, including both the newly discovered and previously known ones.

This suggests a heterogeneous biological basis for stuttering: multiple, distinct molecular routes can give rise to similar speech-related outcomes.
 

Transient vs. persistent: a surprising overlap

Interestingly, the study found no difference in the detection of (likely) pathogenic variants between children with transient and those with persistent stuttering, each group showed comparable yields.
This aligns with large twin and family studies indicating that both transient and persistent stuttering likely share a common genetic foundation, with persistence potentially influenced by additional factors.

Why it matters

This research marks a pivotal moment in stuttering genetics:

• It establishes de novo mutations: new genetic changes not inherited from the parents, as a cause in some cases of stuttering.
• It bridges stuttering to broader neurodevelopmental disorders, opening paths for cross-phenotype exploration.
• It reinforces the idea that stuttering isn’t rooted in a single biological pathway, but instead reflects genetic diversity, with implications for individualized interventions.

To solidify these findings, researchers now need to:

• identify recurring mutations in the same genes across other individuals who stutter to confirm their role, or
• conduct deeper speech-phenotype assessments in people harboring these gene variants, and
• further explore how these genes operate in brain development and function.
   

Over time, these insights will help us better grasp how disparate genetic threads converge on the shared experience of stuttering.

Find the publication here: https://www.nature.com/articles/s41380-025-03170-2.